Treatment of Refractory Status Epilepticus

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine whether propofol or barbiturates should be preferred in the treatment of status epilepticus (continuous seizure activity) refractory to 2 standard antiepileptic agents.

Clinical Trial Description

Refractory status epilepticus (SE) develops in 31%-44% of patients with SE, with a mortality of 16%-23%. Coma induction is advocated for its management. Propofol and barbiturates are the most used agents, but no comparative study has been performed. In consideration of the uncertainty regarding the relative effectiveness, despite several retrospective data, a prospective investigation is needed.

The objective is to assess the effectiveness (SE control, adverse events) of a first course of propofol versus barbiturates in the treatment of refractory SE, in adults with refractory SE not due to cerebral anoxia.

Comparison: Coma induction with standardized doses of propofol or barbiturates titrated towards burst-suppression on EEG, then assessment of the proportion of patients achieving a control of SE. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Status Epilepticus

Clinical Trial Details

NCT number	NCT00265616
Study type	Interventional
Source	Brigham and Women's Hospital
Contact
Status	Terminated
Phase	Phase 3
Start date	May 2006
Completion date	March 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03883516` - Improving Emergency Management of Status Epilepticus	N/A
Recruiting	`NCT03378687` - A Clinical Study of Children With Status Epilepticus in China	N/A
Recruiting	`NCT00362141` - Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus	Phase 2
Recruiting	`NCT05140265` - De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
Active, not recruiting	`NCT04391569` - Randomized Therapy In Status Epilepticus	Phase 3
Recruiting	`NCT06017973` - The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus	N/A
Completed	`NCT06334796` - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology	Early Phase 1
Recruiting	`NCT05491590` - Patient-reported Outcome After Status Epilepticus
Recruiting	`NCT04421846` - Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis	N/A
Completed	`NCT02958605` - Smartphone Apps for Pediatric Resuscitation	N/A
Completed	`NCT02239380` - Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan	Phase 3
Completed	`NCT01796574` - Ketogenic Diet for Refractory Status Epilepticus	N/A
Completed	`NCT02381977` - Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment	N/A
Completed	`NCT00004297` - Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus	Phase 3
Completed	`NCT03905798` - LORA-PITA IV General Investigation
Recruiting	`NCT05591508` - Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus	N/A
Completed	`NCT00735527` - Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children	Phase 3
Recruiting	`NCT06401707` - PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest	Phase 2
Enrolling by invitation	`NCT06403150` - The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus	Phase 4
Recruiting	`NCT05246566` - Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana